Athersys Inc (FRA:4LSA)
€ 0.045 0 (0%) Market Cap: 921,000.00 Enterprise Value: 21.92 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Athersys Inc KOLPanel Event About TREASURE Data Discussion Call Transcript

Jun 14, 2022 / 09:00PM GMT
Release Date Price: €8.78 (+13.76%)
Karen Hunady
Athersys, Inc. - Director of Corporate Communications & IR

Hello, everyone, and welcome to today's panel discussion. My name is Karen Hunady, and I'm the Director of Corporate Communications and Investor Relations at Athersys. And I'd like to thank you for joining us today to learn more about the TREASURE data. The TREASURE study was conducted by Healios, our partner in Japan, and it was a randomized double-blinded, placebo-controlled study evaluating MultiStem administration for the treatment of ischemic stroke.

We have put together an expert panel of key opinion leaders in the field of neurology to discuss their own perspective on the TREASURE data. I do want to thank each one of them for taking the time out of their busy clinical schedules to be here with us today. Dr. Robert Willie Mays, our Vice President of Regenerative Medicine and Head of Neuroscience programs here at Athersys, will be moderating the event today. He's going to be taking questions from all of you on this webinar, and directing those questions to the panelists. We will be answering all the questions

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot